Our null findings imply that the benefits and/or deleterious effects of dietary intake on levels of hepatic steatosis may be the same for MO adults regardless of their level of genetic risk associated with PNPLA3 genotype status. This evidence concerns the gene PNPLA3 and fatty liver disease.